Access cutting-edge peripheral artery disease (pad) treatment through this clinical trial at a research site in Avondale. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Avondale location
Preparing your pre-screening questions…
Access peripheral artery disease (pad) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peripheral artery disease (pad) treatment provided free
Check if you qualify for this peripheral artery disease (pad) clinical trial in Avondale, AZ
No-Cost Study Care
Local to Avondale
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching 2 different experimental drugs called REGN7508 and REGN9933. The study is focused on people who have Peripheral Artery Disease (PAD), which means that the blood vessels in their arms and legs have become too narrow. People with PAD have a higher risk of getting blood clots after procedures like Lower Extremity Revascularization (LER), a procedure to improve blood flow in the legs and feet. The aim of this study is to see how well REGN7508 and REGN9933 prevent life-threatening blood clots in participants with PAD who have recently had LER. The effects of REGN7508 and REGN9933, individually, will also be compared to rivaroxaban and a placebo. The study is looking at several other research questions, including: * What side effects might happen from taking the study drugs and how do they compare to the side effects of rivaroxaban * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drugs (which could make the drugs less effective or could lead to side effects) * If the study drugs affect the ability of the blood to clot normally
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07318610) has an active research site in Avondale, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for peripheral artery disease (pad) treatment options in Avondale, AZ, this clinical trial (NCT07318610) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Avondale research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peripheral artery disease (pad) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all peripheral artery disease (pad) clinical trials near you to find additional studies recruiting in your area.
See all peripheral artery disease clinical trials recruiting in Avondale — not just this study.
Browse Peripheral Artery Disease Trials in Avondale →